Infection Control Today® Editorial Staff

Syphilis cases surge, sparking concerns. Deborah Sesok-Pizzini, MD, discusses what infection prevention and control personnel should know about testing evolution, prevention strategies, and innovations combating spread.

Learn about FendX Technologies' breakthrough nanotechnology, including REPELWRAP film and a spray formulation, designed to prevent the spread of infectious diseases on various surfaces.

Tina Platania discusses the significance of continuous glucose monitors (CGM) in diabetes care, highlighting CCS's individualized approach based on medical necessity. From carefully considering patient needs to collaborating with providers and payers, CCS ensures a highly personalized treatment plan, reflecting their commitment to improving overall health.

CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.

FDA guides the transition from emergency-use-labeled Paxlovid to approved labeling, impacting dispensing sites, providers, and patients.

Due to the increasing frequency of natural disasters such as hurricanes, tornadoes, and forest fires, people living in temporary shelters have a higher risk of infection. To address the situation, APIC has created a guide for infection preventionists.

FDA's latest guidance on 510(k) submissions for sterile devices outlines priorities and updates for traditional and novel sterilization methods, ensuring a comprehensive approach to information inclusion.

Ramin Bastani, Healthvana's CEO, unveils the groundbreaking AI Navigator/Chatbot enhancing patient engagement in sexual health clinics. The HIPAA-compliant tool streamlines inquiries boosts efficiency and prioritizes patient benefits.

VeriSIM Life, a health care technology company, utilizes AI to forecast drug candidates' clinical success, accelerating development and reducing costs. Founder and CEO, Jo Varshney, discusses successful applications, challenges, privacy standards, and advice for leveraging AI in health care operations.

FDA designates vaporized hydrogen peroxide (VHP) as an Established Category A sterilization method, reducing reliance on Ethylene Oxide. Boosting innovation for safer, effective medical device sterilization.

Discover how Merck's V116 vaccine, now under FDA priority review, addresses invasive pneumococcal disease in adults, bridging critical protection gaps with 8 unique serotypes.

An interview with an infectious diseases expert on how respiratory syncytial virus (RSV) impacts populations, current treatments, and best methods for prevention.

A recent study in the American Journal of Infection Control reveals errors in infection prevention adherence among health care professionals during the COVID-19 pandemic, emphasizing the importance of improved training.

Jo Varshney, DVM, PhD, the founder of VeriSIM Life, shares her journey to her current position and the role of courage in it.

GigaGen, a biotech company, secures an $11.8M contract expansion with the US Department of Defense to develop synthetic human antibody treatments for botulinum neurotoxins.

Marking the World Health Organization's World AMR Awareness Week, “Going Blue: Confronting the AMR Challenge,” urges health care providers and the public to educate, follow protocols, and ensure patient safety for antibiotic efficacy.

Unlock the secrets to infection prevention in facelift surgery as renowned surgeons Dr. Konstantin Vasyukevic and Dr. Peter Lee share their expert insights and meticulous protocols in this informative interview.

Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA, and SHEA Chair, highlights IDWeek 2023's hybrid format and discusses the critical topic of antimicrobial resistance, emphasizing the role of vaccines in reducing AMR.

A study of 28 nursing homes and nearly 29,000 residents reveals that universal decolonization significantly lowered infection-related hospitalizations, offering hope for improved healthcare outcomes.

Meriwether County School District prioritizes student safety by implementing CASPR Technology, enhancing air and surface disinfection for a healthier learning environment.

Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level. This makes it an objective tool to inform public response to common seasonal illnesses.

This edition of Infection Intel from Infection Control Today covers infection control and prevention company news out of IDWeek, being held in Boston, Massachusetts, from October 11 to 15, 2023.

Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.

Health Watch USA’s annual conference will examine many aspects of long COVID with speakers from across the globe on November 1, 2023, from 8:30 AM to 2:00 PM EST.

A recent conference highlights patient safety in health care and aims to reduce risks and harm to patients during medical care. It's a response to the growing complexity of health care systems and the resulting increase in patient harm.

All eye drops from Dr. Berne’s Whole Health Products are being recalled after FDA warning on August 24. There are 2 adverse reactions reported so far.

Contaminated eye drops can cause infections ranging from minor to life-threatening.

Eagle Pharmaceuticals randomized its first patient in the Phase 2 study of CAL02, a safe and promising anti-toxin drug that treats severe community-acquired bacterial pneumonia without contributing to antibiotic resistance.

In the upcoming fall, vaccination may be necessary for Eris (EG.5) and FL.1.5.1, as they are believed to be the variants of concern.

A new remote sexual health testing provider is available to US public health officials. It aims to reduce the increasing spread of sexually transmitted infections.